Heartflow, Inc. $HTFL Stock Sold by Lisanti Capital Growth LLC

Lisanti Capital Growth LLC cut its stake in shares of Heartflow, Inc. (NASDAQ:HTFL) by 18.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 155,295 shares of the company’s stock after selling 34,380 shares during the quarter. Heartflow makes up 2.1% of Lisanti Capital Growth LLC’s portfolio, making the stock its 6th largest holding. Lisanti Capital Growth LLC owned about 0.18% of Heartflow worth $7,726,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HTFL. M&G PLC acquired a new stake in shares of Heartflow during the third quarter worth approximately $15,978,000. Pictet Asset Management Holding SA bought a new position in shares of Heartflow in the third quarter valued at approximately $551,000. Inscription Capital LLC acquired a new position in shares of Heartflow in the 3rd quarter worth approximately $209,000. Commonwealth Equity Services LLC acquired a new position in shares of Heartflow in the 3rd quarter worth approximately $1,041,000. Finally, Sterling Capital Management LLC grew its position in Heartflow by 797.9% during the 3rd quarter. Sterling Capital Management LLC now owns 2,532 shares of the company’s stock worth $126,000 after acquiring an additional 2,250 shares during the last quarter.

Heartflow Stock Up 5.9%

Shares of NASDAQ HTFL opened at $59.10 on Thursday. Heartflow, Inc. has a 1 year low of $20.13 and a 1 year high of $60.66. The firm’s 50-day moving average is $51.73 and its 200-day moving average is $35.00.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million during the quarter. Heartflow’s revenue for the quarter was up 47.7% compared to the same quarter last year. As a group, analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Insider Buying and Selling at Heartflow

In other Heartflow news, CFO Vikram Verghese sold 29,714 shares of the company’s stock in a transaction on Friday, September 11th. The shares were sold at an average price of $50.06, for a total transaction of $1,487,482.84. Following the completion of the sale, the chief financial officer owned 184,789 shares in the company, valued at approximately $9,250,537.34. The trade was a 13.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Farquhar sold 38,900 shares of the stock in a transaction on Monday, October 12th. The shares were sold at an average price of $49.57, for a total value of $1,928,273.00. Following the completion of the transaction, the chief executive officer directly owned 283,014 shares in the company, valued at approximately $14,029,003.98. This trade represents a 12.08% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 347,963 shares of company stock valued at $17,210,559. 7.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on HTFL shares. Wells Fargo & Company boosted their price objective on Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Robert W. Baird set a $45.00 price target on Heartflow in a report on Friday, August 14th. Piper Sandler reaffirmed an “overweight” rating and issued a $64.00 price target (up from $45.00) on shares of Heartflow in a report on Tuesday, October 20th. Stifel Nicolaus upped their price target on shares of Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research report on Friday, August 14th. Finally, Wall Street Zen lowered shares of Heartflow from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $48.62.

Heartflow Company Profile

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.